Trials / Completed
CompletedNCT00511979
Comparison of the Effect on the Glucose Infusion Rates Between Inhaled Technosphere Insulin and a Subcutaneous Injection of Regular Human Insulin
Effect of Different Doses of Inhaled Technosphere Insulin on Glucose Infusion Rates During Euglycemic Clamps in Comparison to a Subcutaneous Injection of Regular Human Insulin
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Mannkind Corporation · Industry
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
A prospective, single center, open randomized, six way crossover study comparing the dose response effect of four different doses of Technosphere Insulin after pulmonary function delivery in comparison to s.c. injection of two different doses of regular human insulin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Technosphere Insulin | |
| DRUG | Technosphere insulin | |
| DRUG | Technosphere insulin | |
| DRUG | Regular human insulin |
Timeline
- Start date
- 1999-08-01
- Primary completion
- 2000-02-01
- Completion
- 2000-06-01
- First posted
- 2007-08-06
- Last updated
- 2012-06-26
Source: ClinicalTrials.gov record NCT00511979. Inclusion in this directory is not an endorsement.